Tissue damage and senescence provide critical signals for cellular reprogramming in vivo

Area of Science:

• Cell biology
• Developmental biology
• Regenerative medicine

Background:

• In vivo cellular reprogramming into pluripotent cells is possible but poorly understood.
• Cellular senescence, a response to damage, involves cytokine production and tissue remodeling.
• The interplay between senescence and reprogramming in vivo requires further investigation.

Purpose of the Study:

• To elucidate the mechanisms linking cellular senescence and in vivo reprogramming.
• To investigate the role of senescence in creating a permissive environment for reprogramming.
• To explore the potential of senescence-associated factors in facilitating in vivo reprogramming.

Main Methods:

• In vivo expression of reprogramming factors OCT4, SOX2, KLF4, and cMYC (OSKM) in mice.
• Genetic analysis of the Ink4a/Arf locus and interleukin-6 production.
• Pharmacological inhibition of senescence pathways.
• Assessment of senescence and reprogramming markers in proximity.

Main Results:

• OSKM expression in mice induced both senescence and reprogramming in close proximity.
• OSKM-induced senescence requires the Ink4a/Arf locus.
• Interleukin-6 produced during senescence creates a permissive environment for in vivo reprogramming.
• Conditions associated with senescence, like aging and tissue injury, enhance OSKM reprogramming.

Conclusions:

• Cellular senescence is a key component of the in vivo reprogramming process.
• Senescence, through factors like IL-6, actively promotes reprogramming by creating a suitable tissue microenvironment.
• These findings suggest senescence-associated pathways could be harnessed for regenerative medicine and tissue repair.